ARK Genomic Revolution ETF
ARKG
ARKG
261 hedge funds and large institutions have $535M invested in ARK Genomic Revolution ETF in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 54 increasing their positions, 93 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
41% less call options, than puts
Call options by funds: $98.4M | Put options by funds: $167M
42% less repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 93
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
261
Holding in Top 10
–
Calls
$98.4M
Puts
$167M
Top Buyers
| 1 | +$28.4M | |
| 2 | +$15.3M | |
| 3 | +$14.1M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12.1M |
| 5 |
GS
GTS Securities
New York
|
+$4.28M |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$7.45M | |
| 3 | -$2.5M | |
| 4 |
Two Sigma Investments
New York
|
-$2.49M |
| 5 |
Citigroup
New York
|
-$1.96M |